Idebenone Treatment of Early Parkinson's Diseasesymptoms
Status:
Unknown status
Trial end date:
2021-05-30
Target enrollment:
Participant gender:
Summary
On May 30,2018 ,Investigators intend to conduct a multicenter, randomized, double-blind,
placebo-controlled study of idebenone in the treatment of early-stage Parkinson's disease
with motor and non-motor symptoms which is to observe the therapeutic effect of idebenone on
motor symptoms and non-motor symptoms in patients with early Parkinson's disease。